Really excited to share exciting advances from ASCO and more!
Ready to dive into the latest #ColorectalCancer treatment breakthroughs? Join gastrointestinal medical oncologist @DocDustyD and Fight CRC's research advocacy project manager @Carli_FightCRC, PhD, as they unpack research presented at @ASCO! #ASCO24
fightcrc.zoom.us/webinar/reg…
Dustin Deming retweeted
#CercekPlot @AndreaCercek achieved 42 out of 42 COMPLETE clinical responses in MMRd - #rectalcancer - 100%!! #ASCO24 @ASCO @MSKCancerCenter
Dustin Deming retweeted
Thankful and appreciative of the recognition at the 2024 ASCO Conference. Extra thankful for my supportive wife and family, to @MMably for the nomination and mentorship, and for the opportunity to collaborate with a wonderful team @UWCarbone and @UWMadPharmacy
Dustin Deming retweeted
#ASCO24 CRC Orals:
Completely agree with @KristenCiombor-
Don’t want to see any more neoadj dMMR IO trials reporting path responses (non validated as a relevant surrogate endpoint for colon relapse) with short median follow ups.
Time to set the bar at DFS to report, IMO
Dustin Deming retweeted
#ASCO24 Day 1! Apparently took 0 photos despite QT with many smart ppl. They restore my hope in rapid progress fighting cancers.
@KristenCiombor @benweinbergmd @ben_schlechter @pashtoonkasi @NVijayvergiaMD @smitha42 @adasarimd @DocDustyD @AACRPres @Joleen__Hubbard @niloazad
Dustin Deming retweeted
Management of CRC continues to evolve w/ the intro of new targeted therapies & strategies. An Ed. Session at #ASCO24 will review recent advances & ongoing trials aimed at further improving outcomes: brnw.ch/21wJVF0 #ASCODailyNews #GICSM #colorectalcancer #crcsm @DocDustyD
Dustin Deming retweeted
Congratulations to the 2024 ECOG-ACRIN Young Investigator Award recipient, @DocDustyD of @UWCarbone & @uwsmph! #CancerResearch #ClinicalTrials #ColorectalCancer #ColonCancer #CRCSM – at Baltimore, MD
Dustin Deming retweeted
Yeah, what happens? @DocDustyD shares his story with colorectal cancer from both the patient and researcher perspective. Click the link to learn more.
v.org/story/dr-deming-knows-…
ALT Image of Dr. Deming in his lab. Background is dark blue and red ombre. Text is in white.
Dustin Deming retweeted
Watch a new 3-part panel discussion led by Dr Marwan Fakih on options and opportunities to improve outcomes in patients with advanced #colorectalcancer.
#PeerVoice #CRC #oncology #gastroenterology #AdvancedCRC
@mgfakih @GIcancerdoc @DocDustyD peervoice.com/SCT?PromoCode=…
Dustin Deming retweeted
“I start every new visit by telling the patient who I am, what I’ve been through, and the fact that I’ve been in their shoes," #FightCRC Medical Advisory Board Member and #ColorectalCancer survivor, @DocDustyD shares.
uwhealth.org/news/battling-c…
Dustin Deming retweeted
#ComboMATCH Treatment Trial E5, led by @kspencer725 of @Perlmutter_CC and @DocDustyD of @UWCarbone, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine
Dustin Deming retweeted
CAPOX is not a well-tolerated regimen..here is the real-world data👇presented today at #GI24 @Amitmahipal79 @IbrahimSahinMD1 @NikolasNaleid @JEvaSelfridge @lumish @UHhospitals @OncoThor @pashtoonkasi @realbowtiedoc @bejmedonc @antonyruggeri @Dr_M_Tejani @UH_RE_Institute
Dustin Deming retweeted
Took a stroll down memory lane and noted this all began in 2020! This has been a labor of love a long time in the making, and with the help of many of you it is finally a reality. How fitting it activated at #GI24. I’m coming for you KRAS! @Perlmutter_CC @DocDustyD @eaonc – at San Francisco, CA
Trial Activation: #ComboMATCH treatment trial E5, led by @kspencer725 of @Perlmutter_CC and @DocDustyD of @UWCarbone, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine
Dustin Deming retweeted
New from #ASCOEdBook: Current state, ongoing trials in oligometastatic GI cancer. Read More: brnw.ch/21wGc1b #GI24 @mustafabasree @JeremyKratz @NataliyaUboha #gicsm
Dustin Deming retweeted
We are looking for a GI medical oncologist to join @uw_medicine, @uw_hemeoncpc & @UWCarbone! Work with our supportive team as we continue to grow and thrive in exceptional clinical care and innovative research. Apply now: jobs.wisc.edu/jobs/gi-medica…
Dustin Deming retweeted
Many thanks to the esteemed presenters and panelists who participated in the Robert L. Comis, MD #TranslationalScience Symposium: @KReissMD, Dr. Adalsteinsson, @harpreet_md, @DocDustyD, @md_stewart, @AngieDemichele, & Drs. Gade, Fowler, & Mahmood! #TherapyOptimization – at Washington, DC
Dustin Deming retweeted
Our researchers always amaze us! We're inspired by Dr. Deming's "Don't Ever Give Up!" spirit and commitment to game-changing research as one of our top notch grantees. @DocDustyD is creating a better tomorrow!
Q&A with @DocDustyD 🥼 of @uw_medicine:
#Oncologist’s #colorectalcancer diagnosis ‘changed the way I interact with patients’
#GITwitter
bit.ly/3Kyov4s
Dustin Deming retweeted
When @DocDustyD was diagnosed with #rectalcancer, it changed the way he practiced medicine 🥼 and cared for patients.
“To be honest, I did not get what it meant to hear the word #cancer,” he said.
Learn more about his journey at the 🔗 below:
bit.ly/3Kyov4s
Our prelim study by med student Alyssa DeZeeuw shows potential for carbo/taxol/xrt for localized anal cancer in patients unable to recieve mito/5fu. e15500 #ASCO23 @uw_medicine @uw_hemeoncpc @UWCarbone